126 related articles for article (PubMed ID: 17616670)
1. Alterations of the HBP1 transcriptional repressor are associated with invasive breast cancer.
Paulson KE; Rieger-Christ K; McDevitt MA; Kuperwasser C; Kim J; Unanue VE; Zhang X; Hu M; Ruthazer R; Berasi SP; Huang CY; Giri D; Kaufman S; Dugan JM; Blum J; Netto G; Wazer DE; Summerhayes IC; Yee AS
Cancer Res; 2007 Jul; 67(13):6136-45. PubMed ID: 17616670
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional factor HBP1 targets P16(INK4A), upregulating its expression and consequently is involved in Ras-induced premature senescence.
Li H; Wang W; Liu X; Paulson KE; Yee AS; Zhang X
Oncogene; 2010 Sep; 29(36):5083-94. PubMed ID: 20581871
[TBL] [Abstract][Full Text] [Related]
3. Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1.
Kim J; Zhang X; Rieger-Christ KM; Summerhayes IC; Wazer DE; Paulson KE; Yee AS
J Biol Chem; 2006 Apr; 281(16):10865-75. PubMed ID: 16495219
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor is a direct target of HBP1-mediated transcriptional repression that is overexpressed in prostate cancer.
Chen YC; Zhang XW; Niu XH; Xin DQ; Zhao WP; Na YQ; Mao ZB
Oncogene; 2010 May; 29(21):3067-78. PubMed ID: 20383199
[TBL] [Abstract][Full Text] [Related]
5. miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1.
Li H; Bian C; Liao L; Li J; Zhao RC
Breast Cancer Res Treat; 2011 Apr; 126(3):565-75. PubMed ID: 20505989
[TBL] [Abstract][Full Text] [Related]
6. The expression of the tumour suppressor HBP1 is down-regulated by growth factors via the PI3K/PKB/FOXO pathway.
Coomans de Brachène A; Bollaert E; Eijkelenboom A; de Rocca Serra A; van der Vos KE; Burgering BM; Coffer PJ; Essaghir A; Demoulin JB
Biochem J; 2014 May; 460(1):25-34. PubMed ID: 24762137
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor HBP1 is a direct anti-cancer target of transcription factor FOXO1 in invasive oral cancer.
Chan CY; Huang SY; Sheu JJ; Roth MM; Chou IT; Lien CH; Lee MF; Huang CY
Oncotarget; 2017 Feb; 8(9):14537-14548. PubMed ID: 28099936
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
Li XF; Yan PJ; Shao ZM
Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
[TBL] [Abstract][Full Text] [Related]
9. [Epigenetic inactivation of the WNT antagonist SFRP1 in breast cancer].
Dahl E; Veeck J; An H; Wiesmann F; Klopocki E; Sauter G; Kristiansen G; Hartmann A; Knüchel R
Verh Dtsch Ges Pathol; 2005; 89():169-77. PubMed ID: 18035687
[TBL] [Abstract][Full Text] [Related]
10. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.
Veeck J; Chorovicer M; Naami A; Breuer E; Zafrakas M; Bektas N; Dürst M; Kristiansen G; Wild PJ; Hartmann A; Knuechel R; Dahl E
Oncogene; 2008 Jan; 27(6):865-76. PubMed ID: 17653090
[TBL] [Abstract][Full Text] [Related]
11. Up-regulated NRIP2 in colorectal cancer initiating cells modulates the Wnt pathway by targeting RORβ.
Wen Z; Pan T; Yang S; Liu J; Tao H; Zhao Y; Xu D; Shao W; Wu J; Liu X; Wang Y; Mao J; Zhu Y
Mol Cancer; 2017 Jan; 16(1):20. PubMed ID: 28137278
[TBL] [Abstract][Full Text] [Related]
12. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.
Li HZ; Gao Y; Zhao XL; Liu YX; Sun BC; Yang J; Yao Z
Mol Cancer Res; 2009 Jun; 7(6):832-40. PubMed ID: 19531568
[TBL] [Abstract][Full Text] [Related]
13. The HBP1 transcriptional repressor and the p38 MAP kinase: unlikely partners in G1 regulation and tumor suppression.
Yee AS; Paulson EK; McDevitt MA; Rieger-Christ K; Summerhayes I; Berasi SP; Kim J; Huang CY; Zhang X
Gene; 2004 Jul; 336(1):1-13. PubMed ID: 15225871
[TBL] [Abstract][Full Text] [Related]
14. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration.
Postovit LM; Abbott DE; Payne SL; Wheaton WW; Margaryan NV; Sullivan R; Jansen MK; Csiszar K; Hendrix MJ; Kirschmann DA
J Cell Biochem; 2008 Apr; 103(5):1369-78. PubMed ID: 17685448
[TBL] [Abstract][Full Text] [Related]
16. The HBP1 transcriptional repressor participates in RAS-induced premature senescence.
Zhang X; Kim J; Ruthazer R; McDevitt MA; Wazer DE; Paulson KE; Yee AS
Mol Cell Biol; 2006 Nov; 26(22):8252-66. PubMed ID: 16966377
[TBL] [Abstract][Full Text] [Related]
17. Gene amplification and overexpression of PRDM14 in breast cancers.
Nishikawa N; Toyota M; Suzuki H; Honma T; Fujikane T; Ohmura T; Nishidate T; Ohe-Toyota M; Maruyama R; Sonoda T; Sasaki Y; Urano T; Imai K; Hirata K; Tokino T
Cancer Res; 2007 Oct; 67(20):9649-57. PubMed ID: 17942894
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer.
Ann Surg Oncol; ; . PubMed ID: 17768662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
